News + PR Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use Read More
News + PR Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC Read More
News + PR Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSourceSM Laboratory Read More
News + PR Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City Read More
News + PR Wheeler Bio Licenses ATUM's Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering Read More
News + PR Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma Read More
News + PR Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency across their Cell Line Development Workflow Read More
News + PR Alloy Therapeutics and Echo Investment Capital Create Wheeler Bio to Accelerate the Development of New Antibody Therapeutics Read More
